Skip to main content
Clinical Trials/NCT00579332
NCT00579332CompletedPhase 2

Effects of Brassica or Indole-3-Carbinol on Prostatectomy Patients With PSA Recurrenc

Vanderbilt University1 site in 1 country16 target enrollmentStarted: January 1, 2005Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
16
Locations
1
Primary Endpoint
change in blood PSA levels

Study Overview

Brief Summary

Pilot and feasibility diet and phyto-agent intervention among healthy men at risk for prostate cancer progression.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Men with PSA recurrence following prostatectomy

Exclusion Criteria

  • •Not using exogenous hormones

Arms & Interventions

1

Placebo Comparator

one a day placebo

Intervention: brassica intervention (Dietary Supplement)

2

Experimental

Brassica intake

Intervention: brassica intervention (Dietary Supplement)

3

Experimental

indole-3-carbinol supplement

Intervention: brassica intervention (Dietary Supplement)

Outcomes

Primary Outcomes

change in blood PSA levels

Time Frame: 6 months

Secondary Outcomes

  • monitor for health events(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jay Fowke

Associate Professor

Vanderbilt University

Study Sites (1)

Loading locations...

Similar Trials